Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Benjamin Lowentritt, MD
Chesapeake Urology
Study Chair - Nadeem Sheikh, PhD
Dendreon Pharmaceuticals, LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Urology Specialists
Tuscon, Arizona, United States
Recruiting - City of Hope - National Medical Center
Duarte, California, United States
Recruiting - Urology Associates of Central California Medical Group
Fresno, California, United States
Recruiting - Unio Health Partners - Genesis Research, Llc
San Diego, California, United States
Recruiting - Colorado Urology
Lakewood, Colorado, United States
Recruiting - Advanced Urology Institute
Daytona Beach, Florida, United States
Recruiting - Advanced Urology Institute
Largo, Florida, United States
Recruiting - Advanced Urology Institute
Ocala, Florida, United States
Recruiting - Florida Urology Partners
Riverview, Florida, United States
Recruiting - Associated Urological Specialists
Chicago Ridge, Illinois, United States
Active, not recruiting - Uropartners
Glenview, Illinois, United States
Recruiting - Advanced Urology Associates
New Lenox, Illinois, United States
Recruiting - Urology of Indiana
Carmel, Indiana, United States
Recruiting - First Urology
Jeffersonville, Indiana, United States
Recruiting - Urologic Specialists of Northwest Indiana
Merrillville, Indiana, United States
Recruiting - Chesapeake Urology Research Associates
Towson, Maryland, United States
Recruiting - Michigan Institute of Urology
Troy, Michigan, United States
Recruiting - Specialty Clinical Research of St. Louis
St Louis, Missouri, United States
Recruiting - Integrated Medical Professionals
North Hills, New York, United States
Recruiting - Associated Medical Professionals of Ny
Syracuse, New York, United States
Recruiting - Associated Urologists of North Carolina
Raleigh, North Carolina, United States
Recruiting - the Urology Group
Cincinnati, Ohio, United States
Recruiting - Central Ohio Urology Group
Gahanna, Ohio, United States
Recruiting - Oregon Urology Institute
Springfield, Oregon, United States
Recruiting - Midlantic Urology
Bala-Cynwyd, Pennsylvania, United States
Recruiting - Keystone Urology Specialists
Lancaster, Pennsylvania, United States
Recruiting - Lowcountry Urology Institute
Charleston, South Carolina, United States
Recruiting - Carolina Urologic Research Center, Llc
Myrtle Beach, South Carolina, United States
Recruiting - Urology Associates of Nashville
Nashville, Tennessee, United States
Recruiting - Urology of Virginia
Virginia Beach, Virginia, United States
Recruiting - Spokane Urology
Spokane, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Oct 2023
- Primary completion
- 31 Dec 2031
- Completion
- 30 Jun 2032
- Last update posted
- 27 Aug 2025
- Registered enrollment
- 400
- Registry id
- NCT06134232
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.